Activity Preview

Live

Emerging Treatment Strategies for Mood and Anxiety Disorders

Activity Type:

  • On Demand


Release Date: 2/1/2020

Expiration Date: 2/1/2023

  • AMA PRA Category 1: 1
  • Participation: 1

Register

Overview

Depression is a common disorder, estimated to affect approximately 350 million people worldwide. Depression is costly and one of the main sources of personal suffering and despite available effective treatments depression unfortunately remains often untreated or patients do not respond to conventional treatment approaches. Depression affects people in all communities across the world and is the leading cause of disability worldwide in terms of total years lost. Research has shown that depression is a major factor in attempted/completed suicide.

Generalized anxiety disorder (GAD) affects approximately 5.7% of the population and is the most common form of anxiety disorder found in the primary care setting. If left untreated, GAD is associated with increased societal costs and can substantially reduce the quality of life of the individual patient.

There are different conventional approaches in treatment of mood and anxiety disorders, mainly pharmacological treatment and psychotherapy. Although patients benefit from these methods, there are many people who are sufficiently responding to these treatments.

In this session the speakers will talk about different emerging treatments and approaches for mood and anxiety disorders.

**This content was captured at the 2019 APA Annual Meeting and may reference information from various sources and terminology from previous editions of the DSM.

Pricing

  • General Member - Free
  • Resident-Fellow Member - Free
  • Medical Student Member - Free
  • Non-Member - $25.00

This course is free to APA members through the Course of the Month program. Promotional pricing valid February 1-29, 2020.

Course References

  • Milev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., ... & MacQueen, G. M. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. The Canadian Journal of Psychiatry, 61(9), 561-575.
  • Berlim, M. T., Van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014). Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychological medicine, 44(2), 225-239.

Learning Objectives

  • Compare traditional notions of mental health deliver with recently emerging approaches
  • Demonstrate new techniques and approaches for treatment of depressive and anxiety disorders
  • Provide an overview of current evidence of emerging treatment approaches for assessment, treatment, and monitoring of mental health

Target Audience

Psychiatrists, Residents/Fellows

Estimated Time to Complete

Estimated Duration: 60 minutes
Begin Date: February 1, 2020
End Date: February 1, 2023

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned. 

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The APA designates this enduring CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Program Presenters

  • Stefan Kloiber, M.D., Assistant Professor, Brain and Therapeutics, University of Toronto. Reports no financial relationships with commercial interests.
  • Yuliya Knyahnytska, M.D., Ph.D., Assistant Professor, Brain and Therapeutics, University of Toronto. Reports no financial relationships with commerical interests.
  • Nazanin Alavi, M.D., FRCPC, Assistant Professor, Department of Psychiatry, Queen's University. Disclosure: Stock (Self and Partner) - Canarmony, Inc.
  • Alpna Munshi, M.D., FRCPC. IMG Director and Assistant Professor, Adult Psychiatry and Health Systems, Equity, Gender, and Population, University of Toronto. Reports no financial relationships with commercial interests.
  • Ishrat Husain, MBBS, MD, MRCPsych, Assistant Professor, Brain and Therapeutics, University of Toronto. Reports no financial relationships with commercial interests.

Program Planners

  • Tristan Gorrindo, M.D., Director of Education, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • Katie Putnam, Membership Development Specialist, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • Ally Brown, Senior Program Manager, Online Learning, American Psychiatric Association. Reports no financial relationships with commercial interests.

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

Need Assistance? contact educme@psych.org for questions about this course | contact learningcenter@psych.org for technical assistance

All materials copyright American Psychiatric Association ©2020.

Register